H55 has successfully completed the first part of its Series C financing round securing CHF 45 million in financing. The Valais company has secured the investment of equity and non-dilutive financing in the first phase of
Tags :Luc Defferrard
Walder Wyss advised UBS Switzerland as mandated lead arranger, underwriter and fronting bank on a syndicated credit facilites agreement for Groupe Baume to finance the acquisition of certain participations in the companies of the group
The CABB Group has successfully concluded its refinancing round. New bonds with a total volume of EUR 670 million and terms until 2028 were successfully placed with institutional investors. The issue comprises two tranches: EUR 420 million with
Walder Wyss advised UBS Switzerland as sole mandated lead arranger, sole bookrunner, agent and lender, as well as a syndicate of banks as lenders on a CHF 1.4 billion multicurrency syndicated revolving credit facility for Maus
The German Röchling Group, active worldwide in the field of plastics processing, has acquired Swiss Performance Materials Group with its subsidiary Compotech based in Weinfelden. Compotech specializes in manufacturing molded parts made from glass
German businessman and tech entrepreneur Hakan Koç and former telecoms executive and private equity investor Pyrros Koussios have completed their acquisition of Truphone, the first global mobile operator. They are buying the assets and subsidiaries
RTX Ventures, the venture capital arm of Raytheon Technologies, has made a minority investment in electric propulsion system company H55 to drive the development of electric aviation solutions. This investment aligns with Raytheon Technologies’ longstanding
Walder Wyss has advised Credit Suisse-Switzerland on the mortgage-backed financing for SQUARE ONE with Credit Suisse-Switzerland as coordinator, documentation agent, agent, security agent and lender leading a consortium of banks. The financing supports the future
+ND Capital has exited Dutch cell therapy company CellPoint by sale to the Belgian biotech company Galapagos which has acquired CellPoint for $131 million upfront and up to $105 million in milestone payments. As sole venture investor
XS Participations, a Dutch investment company, has agreed to sell its stake in Twelve Capital Holding, an independent investment manager specializing in investments in the insurance sector, to Graubündner Kantonalbank and management of Twelve
